Home

Latest News

Finance

Telix Pharmaceuticals and University of Melbourne Establish Cancer Translational Research Partnership

Melbourne, Australia, October 18, 2017 – Telix Pharmaceuticals Limited (“Telix”) is pleased to announce that it has...Read More
October 18, 2017
Finance

Telix Pharmaceuticals Files $50 million Underwritten Initial Public Offering

Telix Pharmaceuticals Files $50 million Underwritten Initial Public Offering. Click here to view prospectus....Read More
October 16, 2017

Twitter

University of Melbourne and Telix Pharmaceuticals Establish Cancer Translational Research Partnership https://t.co/eXvfWvfXPC

Load More...